World Health Organization. Global prevalence and incidence of selected curable sexually transmitted infections. Overview and estimates. Geneva, World Health Organization, 2001. WHO/CDS/CSR/EDC/2001.10.
CDC. Sexually transmitted disease surveillance, 2009. Atlanta, GA: US Department of Health and Human Services, CDC; 2010. Available at http://www.cdc.gov/std/stats09/default.htm. Accessed April 6, 2011.http://www.cdc.gov/std/stats09/default.htm
UNAIDA/WHO.USA: Epidemilogical Fact Sheets on HIV/AIDS and STD.2002.Update ; Screening for chlamydial infection: U.S. Preventive Services Task Force recommendation statement // Annals of internal medicine. 2007. Jul. 17. №147(2). Р. 128–134.
Иванова М.А., Поршина О.В., Воронина Л.Г. Социальные аспекты здоровья населения. №4. 2012.
Ripa T., Nilsson P. A variant of Chlamydia trachomatis with deletion in cryptic plasmid: implications for use of PCR diagnostic tests // Euro. Surveill. 2006. №11. E061109.
Ripa T., Nilsson P.A. A Chlamydia trachomatis strain with a 377-bp deletion in the cryptic plasmid causing false-negative nucleic acid amplification tests // Sex. Transm. Dis. 2007. №34. Р. 255–256.
Herrmann B. A new genetic variant of Chlamydia trachomatis // Sex. Transm. Infect. 2007. №83. Р. 253–254.
Catsburg A., van Dommelen L., Smelov V., de Vries H.J.C., Savitcheva A., Domeika M. et al. TaqMan assay for Swedish Chlamydia trachomatis variant // Emerg. Infect. Dis. 2007. №13. Р. 1432–1434.
Lanjouw E., Ossewaarde J.M., Stary A., Boag F. European guideline for the management of Chlamydia trachomatis infections. Available at: http://www.iusti.org/regions/Europe/Euro_Guideline_Chlamydia_2010.pdf. Last accessed: 25, Feb. 2011.http://www.iusti.org/regions/Europe/Euro_Guideline_Chlamydia_2010.pdf
World Health Organization Task Force on the Prevention and Management of Infertility. Tubal infertility: serologic relationship to past chlamydial and gonococcal infection. World Health Organization Task Force on the Prevention and Management of Infertility // Sex. Transm. Dis. 1995. №22. Р. 71–77.
Cates W., Jr., Wasserheit J.N. Genital chlamydial infections: epidemiology and reproductive sequelae // Am. J. Obstet. Gynecol. 1991. №164. Р. 1771–1781.
Hillis S.D., Wasserheit J.N. Screening for chlamydia – a key to the prevention of pelvic inflammatory disease // N. Engl. J. Med. 1996. №334. Р. 1399–1401.
Hillis S.D., Owens L.M., Marchbanks P.A., Amsterdam L.F., Mac Kenzie W.R. Recurrent chlamydial infections increase the risks of hospitalization for ectopic pregnancy and pelvic inflammatory disease // Am. J. Obstet. Gynecol. 1997. №176. Р. 103–107.
Фриго Н.В. и соавт. Лабораторная диагностика ИППП в Российской Федерации. Результаты национального исследования // Вестник дерматологии и венерологии. 2008. №5.
Horner P.J., Crowley T., Leece J., Hughes A., Smith G.D., Caul E.O. Chlamydia trachomatis detection and the menstrual cycle // Lancet. 1998. №351. Р. 341–342.
Møller J.K., Andersen B., Olesen F., Lignell T., Østergaard L. Impact of menstrual cycle on the diagnostic performance of LCR, TMA, and PCE for detection of Chlamydia trachomatis in home obtained and mailed vaginal flush and urine samples // Sex. Transm. Infect. 1999. №75. Р. 228–230.
Ross J., Judlin P., Nilas L. European guideline for the management of pelvic inflammatory disease // Int. J. STD AIDS. 2007. №18. Р. 662–666.
Beatty W.L., Byrne G.I., Morrison R.P. Repeated and persistent infection with Chlamydia and the development of chronic inflammation and disease // Trends in microbiology. 1994. Mar. 2(3). №94(8). Р. 6–19.
Siewert K., Rupp J., Klinger M., Solbach W., Gieffers J. Growth cycle-dependent pharmacodynamics of antichlamydial drugs // Antimicrob Agents Chemother. 2005. №49. Р. 1852–1856.